These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 917042)

  • 1. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis therapy in myasthenia gravis.
    Dau PC
    Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis in myasthenia gravis.
    Dau PC
    Prog Clin Biol Res; 1982; 88():265-85. PubMed ID: 7100216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
    Patzold U; Kalies I; Haas J; Ginda EM
    Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Usefulness of plasmapheresis before thymectomy in the management of myasthenia gravis].
    Iváñez V; Díez-Tejedor E; Lara M; Barreiro P
    Neurologia; 1994; 9(7):277-81. PubMed ID: 7946422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of acetylcholine receptor antibodies in myasthenia gravis].
    Zeitlhofer J; Maida EM; Mamoli B; Mayr N
    Wien Med Wochenschr; 1986 Jul; 136(13):329-32. PubMed ID: 3765651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
    Arsura EL; Bick A; Brunner NG; Namba T; Grob D
    Arch Intern Med; 1986 Jul; 146(7):1365-8. PubMed ID: 3718134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of antenatal myasthenia gravis.
    Carr SR; Gilchrist JM; Abuelo DN; Clark D
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):485-9. PubMed ID: 1870801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of myasthenia gravis with plasmapheresis (author's transl)].
    Reuther P; Wiebecke D; Hertel G; Böske A; Mertens HG
    Dtsch Med Wochenschr; 1979 Dec; 104(51):1806-10. PubMed ID: 520174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmapheresis in the treatment of myasthenia gravis.
    Lenzhofer R; Graninger W; Dittrich C; Mamoli B; Zeitlhofer J; Pateisky K
    Wien Klin Wochenschr; 1983 Apr; 95(8):266-71. PubMed ID: 6603717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine.
    Hohlfeld R; Toyka KV; Besinger UA; Gerhold B; Heininger K
    Ann Neurol; 1985 Mar; 17(3):238-42. PubMed ID: 3873207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].
    Morel E; Raimond F; Goulon-Goëau C; Berrih S; Vernet-Der-Garabedian B; Harb J; Bach JF
    Nouv Presse Med; 1982 May; 11(24):1849-54. PubMed ID: 7110933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravis.
    Nicholson GA; Griffiths LR
    Clin Exp Neurol; 1981; 18():61-9. PubMed ID: 6926393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis.
    Kagotani K; Monden Y; Nakahara K; Fujii Y; Seike Y; Kitamura S; Masaoka A; Kawashima Y
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):7-12. PubMed ID: 4010323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of acetylcholine receptor antibodies and clinical severity of myasthenia gravis in combined immunosuppressive therapy].
    Schumm F; Fateh-Moghadam A; Dichgans J
    Eur Arch Psychiatry Neurol Sci; 1984; 234(4):224-30. PubMed ID: 6526060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognosis of juvenile myasthenia gravis].
    Toifl K; Zeitlhofer J; Vass B
    Padiatr Padol; 1988; 23(3):195-207. PubMed ID: 3186266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thymectomy and immunosuppressive therapy on anti-neuroblastoma antibody levels in patients with myasthenia gravis.
    Müller KM; Nykyri E; Andersson LC
    Acta Neurol Scand; 1991 May; 83(5):336-42. PubMed ID: 2063657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis: a new treatment modality for the patient with severe myasthenia gravis.
    Eppel M; Streib EW
    Nebr Med J; 1982 Apr; 67(4):72-4. PubMed ID: 7088214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.